Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Amelioration of Mucositis in Proton Therapy of Fanconi Anemia Fanca-/- Mice by JP4-039.

Quinn TJ, Ding X, Li X, Wilson GD, Buelow K, Sivananthan A, Thermozier S, Henderson A, Epperly MW, Franicola D, Wipf P, Greenberger JS, Stevens CW, Kabolizadeh P.

In Vivo. 2019 Nov-Dec;33(6):1757-1766. doi: 10.21873/invivo.11666.

PMID:
31662500
2.

Reply to Dickhoff et al. from authors of 'Induction chemoradiotherapy versus chemotherapy alone for superior sulcus lung cancer'.

Robinson LA, Tanvetyanon T, Grubbs D, Antonia S, Creelan B, Fontaine J, Toloza E, Keenan R, Dilling T, Stevens CW, Sommers KE, Vrionis F.

Lung Cancer. 2018 Oct;124:322-323. doi: 10.1016/j.lungcan.2018.08.020. Epub 2018 Aug 29. No abstract available.

PMID:
30193907
3.

Induction chemoradiotherapy versus chemotherapy alone for superior sulcus lung cancer.

Robinson LA, Tanvetyanon T, Grubbs D, Antonia S, Creelan B, Fontaine J, Toloza E, Keenan R, Dilling T, Stevens CW, Sommers KE, Vrionis F.

Lung Cancer. 2018 Aug;122:206-213. doi: 10.1016/j.lungcan.2018.06.021. Epub 2018 Jun 19.

PMID:
30032833
4.

Improved Survival With Increased Time-To-Radiation and Sequential Chemotherapy After Surgery for pN2 Non-Small-cell Lung Cancer.

Sura K, Grills IS, Vu CC, Stevens CW, Ye H, Guerrero TM.

Clin Lung Cancer. 2018 Mar;19(2):e185-e194. doi: 10.1016/j.cllc.2017.10.011. Epub 2017 Nov 20.

PMID:
29158124
5.

Quantitatively Excessive Normal Tissue Toxicity and Poor Target Coverage in Postoperative Lung Cancer Radiotherapy Meta-analysis.

Abuodeh Y, Naghavi AO, Echevarria M, DeMarco M, Tonner B, Feygelman V, Stevens CW, Perez BA, Dilling TJ.

Clin Lung Cancer. 2018 Jan;19(1):e123-e130. doi: 10.1016/j.cllc.2017.06.009. Epub 2017 Jul 8.

PMID:
29107487
6.

The opioid antagonist, β-funaltrexamine, inhibits lipopolysaccharide-induced neuroinflammation and reduces sickness behavior in mice.

Davis RL, Stevens CW, Thomas Curtis J.

Physiol Behav. 2017 May 1;173:52-60. doi: 10.1016/j.physbeh.2017.01.037. Epub 2017 Jan 24.

PMID:
28130086
7.

Single Amino Acid Variation Underlies Species-Specific Sensitivity to Amphibian Skin-Derived Opioid-like Peptides.

Vardy E, Sassano MF, Rennekamp AJ, Kroeze WK, Mosier PD, Westkaemper RB, Stevens CW, Katritch V, Stevens RC, Peterson RT, Roth BL.

Chem Biol. 2015 Jun 18;22(6):764-75. doi: 10.1016/j.chembiol.2015.05.012.

8.

The opioid antagonist, β-funaltrexamine, inhibits NF-κB signaling and chemokine expression in human astrocytes and in mice.

Davis RL, Das S, Thomas Curtis J, Stevens CW.

Eur J Pharmacol. 2015 Sep 5;762:193-201. doi: 10.1016/j.ejphar.2015.05.040. Epub 2015 May 22.

9.

Bioinformatics and evolution of vertebrate nociceptin and opioid receptors.

Stevens CW.

Vitam Horm. 2015;97:57-94. doi: 10.1016/bs.vh.2014.10.002. Epub 2015 Jan 20. Review.

PMID:
25677768
10.

Phase 2 study of concurrent cetuximab plus definitive thoracic radiation therapy followed by consolidation docetaxel plus cetuximab in poor prognosis or elderly patients with locally advanced non-small cell lung cancer.

Dilling TJ, Extermann M, Kim J, Thompson LM, Yue B, Stevens CW, Antonia S, Gray J, Williams C, Haura E, Pinder-Schenck M, Tanvetyanon T, Kim S, Chiappori A.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):828-33. doi: 10.1016/j.ijrobp.2014.07.023. Epub 2014 Sep 9.

PMID:
25216856
11.

Deformable Imaging Capability for the Radiation Therapy Oncology Group (RTOG) Consensus Atlas of Musculoskeletal Anatomy (CAMAS) for Soft Tissue Sarcoma of the Lower Extremities.

Finkelstein SE, Trotti A, Letson G, Russell M, Delaney TF, Alektiar KM, Michalski JM, Wang D, Kadir T, Stevens CW; et al.

Pract Radiat Oncol. 2013 Apr-Jun;3(2 Suppl 1):S7. doi: 10.1016/j.prro.2013.01.024. Epub 2013 Mar 25. No abstract available.

PMID:
24674567
12.

Effects of Noise in 4D CT on Deformable Image Registration and Derived Ventilation Data.

Zhang GG, Latifi K, Huang T, Feygelman V, Stevens CW, Dilling TJ, Moros EG, Elmpt Wv, Dekker A.

Pract Radiat Oncol. 2013 Apr-Jun;3(2 Suppl 1):S7-8. doi: 10.1016/j.prro.2013.01.025. Epub 2013 Mar 25. No abstract available.

PMID:
24674566
13.

Evaluating Effects of Radiation Therapy Treatment on 4DCT-Calculated Lung Ventilation.

Latifi K, Dilling TJ, Hoffe SE, Stevens CW, Moros EG, Zhang GG.

Pract Radiat Oncol. 2013 Apr-Jun;3(2 Suppl 1):S6-7. doi: 10.1016/j.prro.2013.01.022. Epub 2013 Mar 25. No abstract available.

PMID:
24674563
14.

New pathways for an old molecule: the role of the Na⁺-K⁺ ATPase pump in peripheral neuropathy.

Stevens CW.

J Neurol Sci. 2014 May 15;340(1-2):3-4. doi: 10.1016/j.jns.2014.03.013. Epub 2014 Mar 14. No abstract available.

PMID:
24667006
15.

Study of 201 non-small cell lung cancer patients given stereotactic ablative radiation therapy shows local control dependence on dose calculation algorithm.

Latifi K, Oliver J, Baker R, Dilling TJ, Stevens CW, Kim J, Yue B, Demarco M, Zhang GG, Moros EG, Feygelman V.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1108-13. doi: 10.1016/j.ijrobp.2013.12.047. Epub 2014 Feb 12.

PMID:
24529716
16.

Normalization of ventilation data from 4D-CT to facilitate comparison between datasets acquired at different times.

Latifi K, Feygelman V, Moros EG, Dilling TJ, Stevens CW, Zhang GG.

PLoS One. 2013 Dec 17;8(12):e84083. doi: 10.1371/journal.pone.0084083. eCollection 2013.

17.

Effects of quantum noise in 4D-CT on deformable image registration and derived ventilation data.

Latifi K, Huang TC, Feygelman V, Budzevich MM, Moros EG, Dilling TJ, Stevens CW, van Elmpt W, Dekker A, Zhang GG.

Phys Med Biol. 2013 Nov 7;58(21):7661-72. doi: 10.1088/0031-9155/58/21/7661. Epub 2013 Oct 11.

PMID:
24113375
18.

Β-funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytes.

Davis RL, Das S, Buck DJ, Stevens CW.

Neurochem Int. 2013 Mar;62(4):478-85. doi: 10.1016/j.neuint.2013.01.013. Epub 2013 Jan 31.

19.

Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4.

Stevens CW, Aravind S, Das S, Davis RL.

Br J Pharmacol. 2013 Mar;168(6):1421-9. doi: 10.1111/bph.12028.

20.

Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung.

Baker R, Han G, Sarangkasiri S, DeMarco M, Turke C, Stevens CW, Dilling TJ.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):190-5. doi: 10.1016/j.ijrobp.2012.03.041. Epub 2012 Aug 25.

PMID:
22929858
21.

Volumetric modulated arc planning for lung stereotactic body radiotherapy using conventional and unflattened photon beams: a dosimetric comparison with 3D technique.

Zhang GG, Ku L, Dilling TJ, Stevens CW, Zhang RR, Li W, Feygelman V.

Radiat Oncol. 2011 Nov 9;6:152. doi: 10.1186/1748-717X-6-152.

22.

Analysis of incidental radiation dose to uninvolved mediastinal/supraclavicular lymph nodes in patients with limited-stage small cell lung cancer treated without elective nodal irradiation.

Ahmed I, DeMarco M, Stevens CW, Fulp WJ, Dilling TJ.

Med Dosim. 2011 Winter;36(4):440-7. doi: 10.1016/j.meddos.2010.11.002. Epub 2011 Mar 11.

PMID:
21397488
23.

Analgesia in amphibians: preclinical studies and clinical applications.

Stevens CW.

Vet Clin North Am Exot Anim Pract. 2011 Jan;14(1):33-44. doi: 10.1016/j.cvex.2010.09.007. Review.

24.

Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1β: evidence for opioid-immune crosstalk.

Mohan S, Davis RL, DeSilva U, Stevens CW.

J Neuroimmunol. 2010 Oct 8;227(1-2):26-34. doi: 10.1016/j.jneuroim.2010.06.007. Epub 2010 Jul 7.

25.

Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?

Barthel JS, Kucera ST, Lin JL, Hoffe SE, Strosberg JR, Ahmed I, Dilling TJ, Stevens CW.

Gastrointest Endosc. 2010 Feb;71(2):235-40. doi: 10.1016/j.gie.2009.09.038. Epub 2009 Dec 8.

PMID:
20003971
26.

The evolution of vertebrate opioid receptors.

Stevens CW.

Front Biosci (Landmark Ed). 2009 Jan 1;14:1247-69. Review.

27.
28.

A pharmacological comparison of the cloned frog and human mu opioid receptors reveals differences in opioid affinity and function.

Brasel CM, Sawyer GW, Stevens CW.

Eur J Pharmacol. 2008 Dec 3;599(1-3):36-43. doi: 10.1016/j.ejphar.2008.09.043. Epub 2008 Oct 9.

29.

Nociceptin produces antinociception after spinal administration in amphibians.

Stevens CW, Martin KK, Stahlheber BW.

Pharmacol Biochem Behav. 2009 Jan;91(3):436-40. doi: 10.1016/j.pbb.2008.08.022. Epub 2008 Sep 5.

30.

Personalized treatment approaches in radiation oncology: the future is now.

Harris EE, Stevens CW.

Cancer Control. 2008 Apr;15(2):100-1. No abstract available.

PMID:
18488854
31.

Evolution and faith: empathy is misplaced.

Stevens CW.

Science. 2008 May 9;320(5877):745. doi: 10.1126/science.320.5877.745b. No abstract available.

PMID:
18467570
32.

Predicting response to clinical radiotherapy: past, present, and future directions.

Torres-Roca JF, Stevens CW.

Cancer Control. 2008 Apr;15(2):151-6. Review.

PMID:
18376382
33.

Functional lung imaging in thoracic cancer radiotherapy.

Zhang G, Dilling TJ, Stevens CW, Forster KM.

Cancer Control. 2008 Apr;15(2):112-9. Review.

PMID:
18376378
34.

Beta-funaltrexamine inhibits inducible nitric-oxide synthase expression in human astroglial cells.

Davis RL, Buck DJ, Saffarian N, Mohan S, DeSilva U, Fernando SC, Stevens CW.

J Neuroimmune Pharmacol. 2008 Sep;3(3):150-3. doi: 10.1007/s11481-008-9102-x. Epub 2008 Feb 16.

35.

Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.

Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, Walsh GL, Swisher SG, Hofstetter WL, Mehran RJ, Roth JA, Liao Z, Smythe WR.

Ann Thorac Surg. 2007 Nov;84(5):1685-92; discussion 1692-3.

PMID:
17954086
36.

Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition).

Robinson LA, Ruckdeschel JC, Wagner H Jr, Stevens CW; American College of Chest Physicians.

Chest. 2007 Sep;132(3 Suppl):243S-265S.

PMID:
17873172
37.

The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells.

Davis RL, Buck DJ, Saffarian N, Stevens CW.

J Neuroimmunol. 2007 May;186(1-2):141-9. Epub 2007 May 1.

38.

Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.

Rice DC, Smythe WR, Liao Z, Guerrero T, Chang JY, McAleer MF, Jeter MD, Correa A, Vaporciyan AA, Liu HH, Komaki R, Forster KM, Stevens CW.

Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):350-7. Epub 2007 Apr 30.

PMID:
17467922
40.

Assessment of lung tumor motion and setup uncertainties using implanted fiducials.

Nelson C, Starkschall G, Balter P, Morice RC, Stevens CW, Chang JY.

Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):915-23.

PMID:
17293241
41.
42.

Systemic and spinal administration of the mu opioid, remifentanil, produces antinociception in amphibians.

Mohan S, Stevens CW.

Eur J Pharmacol. 2006 Mar 18;534(1-3):89-94. Epub 2006 Feb 17.

43.

Radiotherapy for mesothelioma.

Stevens CW, Forster KM, Smythe WR, Rice D.

Hematol Oncol Clin North Am. 2005 Dec;19(6):1099-115, vii. Review.

PMID:
16325126
44.

Extended surgical staging for potentially resectable malignant pleural mesothelioma.

Rice DC, Erasmus JJ, Stevens CW, Vaporciyan AA, Wu JS, Tsao AS, Walsh GL, Swisher SG, Hofstetter WL, Ordonez NG, Smythe WR.

Ann Thorac Surg. 2005 Dec;80(6):1988-92; discussion 1992-3.

PMID:
16305830
45.

Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer.

Chandra A, Guerrero TM, Liu HH, Tucker SL, Liao Z, Wang X, Murshed H, Bonnen MD, Garg AK, Stevens CW, Chang JY, Jeter MD, Mohan R, Cox JD, Komaki R.

Radiother Oncol. 2005 Dec;77(3):247-53. Epub 2005 Nov 17.

PMID:
16298001
46.

Imaging of the patient with non-small cell lung cancer.

Munden RF, Swisher SS, Stevens CW, Stewart DJ.

Radiology. 2005 Dec;237(3):803-18. Epub 2005 Oct 26. Review.

PMID:
16251391
47.

Semiautomated four-dimensional computed tomography segmentation using deformable models.

Ragan D, Starkschall G, McNutt T, Kaus M, Guerrero T, Stevens CW.

Med Phys. 2005 Jul;32(7):2254-61.

PMID:
16121580
48.

Intensity-modulated radiation therapy for mesothelioma: impact of multileaf collimator leaf width and pencil beam size on planning quality and delivery efficiency.

Zhu XR, Prado K, Liu HH, Guerrero TM, Jeter M, Liao Z, Rice D, Forster K, Stevens CW.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1525-34.

PMID:
16029815
49.

Semiautomated four-dimensional computed tomography segmentation using deformable models.

Ragan D, Starkschall G, McNutt T, Kaus M, Guerrero T, Stevens CW.

Med Phys. 2005 Jul;32(7Part1):2254-2261. doi: 10.1118/1.1929207.

PMID:
28493567
50.

Treatment planning system evaluation for mesothelioma IMRT.

Stevens CW, Wong PF, Rice D, Jeter M, Forster K, Zhu XR.

Lung Cancer. 2005 Jul;49 Suppl 1:S75-81. Erratum in: Lung Cancer. 2005 Dec;50(3):425. Jeeter, Melenda [corrected to Jeter, Melenda].

PMID:
15950806

Supplemental Content

Loading ...
Support Center